| Range | 6M |
|---|---|
| First date | — |
| Last date | — |
| Open | — |
| High | — |
| Low | — |
| Close | — |
| Volume | — |
| Plotted bars | 0 |
Event records
Event records load after the price chart.
Healthcare · Medical Devices
The Quantellect read. QDEL fell 3.04% in the Nov 18 session to $9.57, which is 73.0% below its 52-week high of $35.38. Four active firms cover the stock as of Nov 19, 2026; three active firms with targets average $14.17 over 12 months. Descriptive summary of the data on this page, not a recommendation.
—
RSI (14) 44.2 (overbought above 70, oversold below 30)
—
—
Price $9.57 · As of Nov 18, 2026, 3:59 PM ET
| Range | 6M |
|---|---|
| First date | — |
| Last date | — |
| Open | — |
| High | — |
| Low | — |
| Close | — |
| Volume | — |
| Plotted bars | 0 |
Event records load after the price chart.
| Range | 6M |
|---|---|
| First close | — |
| Last close | — |
| High | — |
| Low | — |
| Volume | — |
QDEL · NASDAQ · USD
Split-adjusted · volume in shares
— · Notable price movement not available
— · Options flow not available
— · Industry comparison not available
Neutral
Based on 4 active firms as of Nov 19, 2026 (365-day activity window)
As of Nov 19, 2026 across 3 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →— · Smart-money activity not available
All smart-money activity →Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.